Detection of anti-pertussis toxin IgG in oral fluids for use in diagnosis and surveillance of Bordetella pertussis infection in children and young adults. by Litt, D, Samuel, D, Duncan, J, Harnden, A, George, R, Harrison, T

“…Serum IgG titres against pertussis toxin (PT) are routinely used as a marker of recent or persisting B. pertussis infection. …”

Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay. by Fry, N, Litt, D, Duncan, J, Vaghji, L, Warrener, L, Samuel, D, Andrews, N, Harnden, A, Harrison, T

“…Recent vaccination with pertussis vaccine can confound serological and oral fluid (OF) assays targeting anti-pertussis toxin (anti-PT) IgG antibodies as a marker of recent infection. …”

Pertussis-induced cough. by Wang, K, Harnden, A

“…Single estimates of anti-pertussis toxin (PT) antibody titres in blood or oral fluid samples are highly specific. …”

Pertussis-induced cough by Wang, K, Harnden, A

“…Single estimates of anti-pertussis toxin (PT) antibody titres in blood or oral fluid samples are highly specific. …”

Whooping cough in school age children presenting with persistent cough in UK primary care after introduction of the preschool pertussis booster vaccination: prospective cohort stud... by Wang, K, Fry, N, Campbell, H, Amirthalingam, G, Harrison, T, Mant, D, Harnden, A

“…MAIN OUTCOME MEASURES: Evidence of recent pertussis infection based on an oral fluid anti-pertussis toxin IgG titre of at least 70 arbitrary units. …”

Whooping cough in school age children presenting with persistent cough in UK primary care after introduction of the preschool pertussis booster vaccination: prospective cohort stud... by Wang, K, Fry, N, Campbell, H, Amirthalingam, G, Harrison, T, Mant, D, Harnden, A

“…<br/> <b>Main outcome measures:</b> Evidence of recent pertussis infection based on an oral fluid anti-pertussis toxin IgG titre of at least 70 arbitrary units. …”

Montelukast for postinfectious cough in adults: A double-blind randomised placebo-controlled trial by Wang, K, Taylor, K, Jin, J, Perera, R, Farmer, A, Mant, D, Harnden, A, Birring, S, Fry, N, Harrison, T, Hay, A, Moore, M, Little, P

“…Patients were tested for pertussis (oral fluid anti-pertussis toxin IgG) and randomly assigned (1:1) to montelukast 10 mg daily or image-matched placebo for 2 weeks. …”

Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial. by Wang, K, Birring, S, Taylor, K, Fry, N, Hay, A, Moore, M, Jin, J, Perera, R, Farmer, A, Little, P, Harrison, T, Mant, D, Harnden, A

“…Patients were tested for pertussis (oral fluid anti-pertussis toxin IgG) and randomly assigned (1:1) to montelukast 10 mg daily or image-matched placebo for 2 weeks. …”

Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial by Wang, K, Birring, S, Taylor, K, Fry, N, Hay, A, Moore, M, Jin, J, Perera, R, Farmer, A, Little, P, Harrison, T, Mant, D, Harnden, A

“…Patients were tested for pertussis (oral fluid anti-pertussis toxin IgG) and randomly assigned (1:1) to montelukast 10 mg daily or image-matched placebo for 2 weeks. …”